Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
In a surgical biopsy, a medical professional removes samples of cells or tissue that pathologists analyze for diseases such as cancer. By delivering these capabilities through a compact, AI-powered imaging system within the treatment room, Invenio aims to support rapid clinical decision-making.
This technology will help surgeons make intraoperative decisions when performing a biopsy or surgery, said Chris Freudiger, chief technology officer of Silicon Valley-based Invenio. They'll be able to rapidly evaluate whether the tissue sample contains cancerous cells, decide whether they need to take another tissue sample and, with the AI models Invenio is developing, potentially make a molecular diagnosis for personalized medical treatment within minutes.
Quicker diagnosis enables quicker treatment. It's especially critical for aggressive types of cancer that could grow or spread significantly in the weeks it takes for biopsy results to return from a dedicated pathology lab.
Invenio is a member of NVIDIA Inception, a program that provides cutting-edge startups with technological support and AI platform guidance. The company accelerates AI training and inference using NVIDIA GPUs and software libraries.
Laser Focus on Cancer Care The NIO Laser Imaging System accelerates the imaging of fresh tissue biopsies. Invenio's NIO Laser Imaging System is a digital pathology tool that accelerates the imaging of fresh tissue biopsies. It's been used in thousands of procedures in the U.S. and Europe. In 2021, it received the CE Mark of regulatory approval in Europe.
The company plans to adopt the NVIDIA Jetson Orin series of edge AI modules for its next-generation imaging system, which will feature near real-time AI inference accelerated by the NVIDIA TensorRT SDK.
We're building a layer of AI models on top of our imaging capabilities to provide physicians with not just the diagnostic image but also an analysis of what they're seeing, Freudiger said. With the AI performance provided by NVIDIA Jetson at the edge, they'll be able to quickly determine what kinds of cancer cells are present in a biopsy image.
Invenio uses a cluster of NVIDIA RTX A6000 GPUs to train neural networks with tens of millions of parameters on pathologist-annotated images. The models were developed using the TensorFlow deep learning framework and trained on images acquired with NIO imaging systems.
The most powerful capability for us is the expanded VRAM on the RTX A6000 GPUs, which allows us to load large batches of images and capture the variability of features, Freudiger said. It makes a big difference for AI training.
On the Path to Clinical Deployment One of Invenio's AI products, NIO Glioma Reveal, is approved for clinical use in Europe and available for research use in the U.S. to help identify areas of cancerous cells in brain tissue.
A team of Invenio's collaborators from the University of Michigan, New York University, University of California San Francisco, the Medical University of Vienna and University Hospital of Cologne recently developed a deep learning model that can find biomarkers of cancerous tumors with 93% accuracy in 90 seconds.
With this ability to analyze different molecular subtypes of cancer within a tissue sample, doctors can predict how well a patient will respond to chemotherapy - or determine whether a tumor has been successfully removed during surgery.
Beyond its work on brain tissue analysis, Invenio this year announced a clinical research collaboration with Johnson & Johnson's Lung Cancer Initiative to develop and validate an AI solution that can help evaluate lung biopsies. The AI model will help doctors rapidly determine whether collected tissue samples contain cancer.
Lung cancer is the world's deadliest form of cancer, and in the U.S. alone, lung nodules are found in over 1.5 million patients each year. Once approved for clinical use, Invenio's NIO Lung Cancer Reveal tool aims to shorten the time needed to analyze tissue biopsies for these patients.
As part of this initiative, Invenio will run a clinical study before submitting the NVIDIA Jetson-powered AI solution for FDA approval.
Subscribe to NVIDIA healthcare news.
North America Stories
07/01/2026
SVG Summit 2025: All General Sessions Now Available to Watch on SVG PLAYThe SVG Summit celebrated its 20th edition with a loaded agendaBy Brandon Costa, Directo...
07/01/2026
NBCU's Brings Rinkside Live' and Courtside Live' Features to Peaco...
07/01/2026
NASA's Space Launch System rocket carrying the Orion spacecraft launches on the Artemis I flight test, Wednesday, Nov. 16, 2022, from Launch Complex 39B at ...
07/01/2026
For the first time ever, new C' variants allow international users to interoperate with U.S. personnel via NSA-certified cryptography....
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
07/01/2026
Back to All News
The Trailer of Paparazzi King: The 5-Episode Docuseries Coming...
07/01/2026
Back to All News
Netflix Supports Warner Bros. Discovery Board's Commitment...
07/01/2026
Back to All News
What Next? Netflix Reveals Series, Films and Games Coming in 2026
Entertainment
07 January 2026
Global
Link copied to clipboard
Download ...
07/01/2026
AI has transformed retail and consumer packaged goods (CPG) operations, enhancin...
06/01/2026
Peacock Bringing Dolby Vision and Dolby Atmos to Live Sports ContentPeacock is the first streamer to embrace Dolbys full suite of advanced picture/sound innovat...
06/01/2026
SVG Europe Audio: Listening to the sounds of powder and ice at Milano Cortina wi...
06/01/2026
Quintar Meta Spatial SDK Integration Promises Next-Level XR ExperiencesBy Ken Kerschbaumer, Editorial Director
Tuesday, January 6, 2026 - 9:41 am
Print This...
06/01/2026
Milano Cortina 2026: BBC Sport Previews Broadcast Ops, Studio Setup, Social Medi...
06/01/2026
Dolby's Jason Power on Elevating Live Sports Through Immersive Audio and HDR...
06/01/2026
DAZN's Global CRO Walker Jacobs on the Streamer's Breakout Year in the U...
06/01/2026
California Dreamin': LA28's SVP of Media Jim Bell Previews the Olympic a...
06/01/2026
One Month Out From Winter Olympics Opening Ceremony, NBC Sports in Final Prep fo...
06/01/2026
Advanced HDR by Technicolor and Zinwell Integrated onto ATSC 3.0 Conversion Boxe...
06/01/2026
Fox Sports President and COO Mark Silverman Shifts to Consulting RoleBy Ken Kerschbaumer, Editorial Director
Tuesday, January 6, 2026 - 2:37 pm
Print This S...
06/01/2026
In a live broadcast, L3Harris CFO and Missile Solutions President Ken Bedingfield joined Morgan Brennan on CNBCs Closing Bell: Overtime. Bedingfield discussed...
06/01/2026
First-of-its-kind SSP capability delivers program-level insight and brand suitab...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
06/01/2026
Boston Conservatory at Berklee Kicks Off Spring Center Stage Season in February Boston Conservatory at Berklee's Center Stage season continues this spring...
06/01/2026
Operative, the preferred advertising management solution provider for the world's leading media brands, today announced a new AOS Services Platform, advanci...
06/01/2026
Beam Dynamics has strengthened its leadership team with two appointments to support the company's next stage of growth. Jonathan Rollman will lead product s...
06/01/2026
MNC Software, a global leader in network management and operational support systems tailored to the broadcast and media industry, has today announced the appoin...
06/01/2026
Friend MTS, the number one anti-piracy provider and video cybersecurity partner in entertainment, media and sports, today announced a partnership with Jasmine I...
06/01/2026
Kiloview, a global leader in AV-over-IP solutions, will showcase its latest innovations at ISE 2026, highlighting the continued evolution of its complete, light...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
06/01/2026
Share Share by:
Copy link
Facebook
X
Whatsapp
Pinterest
Flipboard...
Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
